Seoul, South Korea

Un-Gi Kim

This inventor holds 2 USPTO granted patents. Top assignee: Toolgen Inc.. Active years: 2023-2025.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Un-Gi Kim: Innovator in Protein Expression Technology

Introduction

Un-Gi Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the area of protein expression. His innovative work aims to address genetic disorders and improve bodily functions through advanced genetic manipulation techniques.

Latest Patents

Un-Gi Kim holds a patent for a platform designed for expressing a protein of interest in the liver. This platform allows for the alleviation or treatment of genetic disorders by inducing expression through the insertion of a transgene into a high-expression secretory gene. The high-expression secretory gene includes the HP or APOC3 gene, which plays a crucial role in the therapeutic process. The transgene is selected for its ability to be highly expressed using a promoter in a hepatocyte genome and is secreted out of the cell.

Career Highlights

Un-Gi Kim is associated with Toolgen Inc., a company that focuses on innovative genetic technologies. His work at Toolgen has positioned him as a key player in the development of therapeutic solutions for genetic conditions. His expertise in manipulating liver functions has opened new avenues for research and treatment.

Collaborations

Un-Gi Kim collaborates with notable colleagues, including Seokjoong Kim and Dong Woo Song. These partnerships enhance the research and development efforts at Toolgen Inc., fostering an environment of innovation and discovery.

Conclusion

Un-Gi Kim's contributions to protein expression technology represent a significant advancement in biotechnology. His innovative approaches have the potential to transform the treatment of genetic disorders and improve health outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…